Southern Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Sell
3,148
-117
-4% -$25.2K 0.2% 24
2026
Q1
$710K Sell
3,265
-42
-1% -$9.32K 0.2% 23
2025
Q4
$756K Buy
+3,307
New +$753K 0.22% 19

Other funds holding ABBV

Southern Financial Group's ABBV Position: Q2 2026 in Review

Southern Financial Group reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $25.2K and leaving 3,148 shares worth $792K. The position accounts for 0.2% of the portfolio, ranked #24.

Southern Financial Group first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,493 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Southern Financial Group held 3,148 shares of AbbVie worth $792K as of Q2 2026.
  • Southern Financial Group sold 117 AbbVie shares in Q2 2026, an estimated $25.2K.
  • AbbVie made up 0.2% of Southern Financial Group's portfolio in Q2 2026, its #24 holding.
  • Southern Financial Group first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,493 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Southern Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.